The Effects of a Weight-Loss Herbal Formula RCM-107 and Its Eight Individual Ingredients on Glucagon-Like Peptide-1 Secretion—An In Vitro and In Silico Study

The Effects of a Weight-Loss Herbal Formula RCM-107 and Its Eight Individual Ingredients on Glucagon-Like Peptide-1 Secretion—An In Vitro and In Silico Study

Obesity is a multifactorial disease that can lead to other health issues. Glucagon-like peptide-1(GLP-1), as one of the satiety signal, has been linked with appetite suppression and weight loss. Due to the limitations of GLP-1 and its analogues, alternative treatments such as herbal therapies have b...

Full description

Bibliographic Details
Main Authors:	Shiqi Luo, Harsharn Gill, Bryce Feltis, Andrew Hung, Linh Toan Nguyen, George Binh Lenon
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	International Journal of Molecular Sciences
Subjects:	GLP-1 secretion appetite suppression obesity overweight cell culture in silico analysis
Online Access:	https://www.mdpi.com/1422-0067/21/8/2854

Similar Items

The effect of lesser yam based cookies on fasting glucagon-like peptide 1, appetite, and dietary intake in overweight/obese with ad libitum diet
by: Harry Freitag Luglio Muhammad, et al.
Published: (2019-01-01)

The inhibitory effects of an eight-herb formula (RCM-107) on pancreatic lipase: enzymatic, HPTLC profiling and in silico approaches
by: Shiqi Luo, et al.
Published: (2019-09-01)

Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches.
by: Shiqi Luo, et al.
Published: (2020-01-01)

Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity
by: Erin D. Michos, et al.
Published: (2023-06-01)

Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis
by: Yuwei Shao, et al.
Published: (2022-08-01)

Evaluation the activity of Neuropeptide Y (NPY), Glucagon like peptide-1 and Ghrelin in controlling appetite in obesity in Erbil City
by: Sawen Tahseen Taha ,Leweza Belal Abbas
Published: (2023-02-01)

The Effects of Exercise on Appetite-Regulating Hormone Concentrations over a 36-h Fast in Healthy Young Adults: A Randomized Crossover Study
by: Landon S. Deru, et al.
Published: (2023-04-01)

GLP-1 responds to postprandial hyperglycemia by reducing transcription level in grass carp (Ctenopharyngodon idella)
by: Yuting Xie, et al.
Published: (2022-04-01)

Stimulants for the control of hedonic appetite
by: Alison Sally Poulton, et al.
Published: (2016-04-01)

Uso de moderadores de apetite entre estudantes da área da saúde na Região Sul do Brasil
by: Carlos Zubaran, et al.

Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
by: Teshome G, et al.
Published: (2020-09-01)

Glucagon‐like peptide agonists: A prospective review
by: Zamara Mariam, et al.
Published: (2024-01-01)

Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action
by: Dan M. Cooper, et al.
Published: (2023-01-01)

Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022-01-01)

Are Dietary Proteins the Key to Successful Body Weight Management? A Systematic Review and Meta-Analysis of Studies Assessing Body Weight Outcomes after Interventions with Increased Dietary Protein
by: Thea Toft Hansen, et al.
Published: (2021-09-01)

Editorial: Appetite Control in Obesity
by: Alessio Molfino, et al.
Published: (2022-06-01)

Effects of probiotic and alpha-lipoic acid supplements, separately or in combination on appetite in overweight individuals: A double blind randomized clinical trial
by: Gholamreza Nasiri, et al.
Published: (2020-09-01)

Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion
by: Nalini Sodum, et al.
Published: (2024-01-01)

The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials
by: Aldawsari M, et al.
Published: (2023-03-01)

Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research
by: Xiaoyan Yang, et al.
Published: (2022-03-01)

Glucagon and Neuromedin U Suppress Food Intake in Broiler Chicks
by: Kazuhisa Honda, et al.
Published: (2015-10-01)

The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
by: Amaara Marzook, et al.
Published: (2021-05-01)

Discrepancy between the Actions of Glucagon-like Peptide-1 Receptor Ligands in the Protection of the Heart against Ischemia Reperfusion Injury
by: Ali Ismaeil, et al.
Published: (2022-06-01)

Oat Polar Lipids Improve Cardiometabolic-Related Markers after Breakfast and a Subsequent Standardized Lunch: A Randomized Crossover Study in Healthy Young Adults
by: Mohammad Mukul Hossain, et al.
Published: (2021-03-01)

Bright Light for Weight Loss: Results of a Controlled Crossover Trial
by: Konstantin V. Danilenko, et al.
Published: (2013-02-01)

Glucagon Shows Higher Sensitivity than Insulin to Grapeseed Proanthocyanidin Extract (GSPE) Treatment in Cafeteria-Fed Rats
by: Carme Grau-Bové, et al.
Published: (2021-03-01)

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures
by: Aleksandra Mieczkowska, et al.
Published: (2021-08-01)

The effects of Fc fusion protein glucagon-like peptide-1 and glucagon dual receptor agonist with different receptor selectivity in vivo studies
by: Peng Jiang, et al.
Published: (2024-05-01)

Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
by: Syed Faizan Mehdi, et al.
Published: (2023-05-01)

Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity
by: Tohru Hira, et al.
Published: (2021-06-01)

Efficacy and safety of dulaglutide: a novel once-weekly glucagon-like peptide-1 analogue
by: A. S. Pogorelova, et al.
Published: (2018-03-01)

Glucagon-like Peptide-1 Levels and Related Parameters in Rheumatoid Arthritis Patients Prone to Atherosclerosis
by: Noorhan K. Shafeeq, et al.
Published: (2017-06-01)

Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
by: Isabella Zaffina, et al.
Published: (2023-02-01)

Increasing doses of fiber do not influence short-term satiety or food intake and are inconsistently linked to gut hormone levels
by: Holly J. Willis, et al.
Published: (2010-06-01)

The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
by: Juan Pang, et al.
Published: (2022-11-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Glucagon-like peptide-2 reduces the obesity-associated inflammation in the brain
by: Domenico Nuzzo, et al.
Published: (2019-01-01)

The Triple Combination Phentermine Plus 5-HTP/Carbidopa Leads to Greater Weight Loss, With Fewer Psychomotor Side Effects Than Each Drug Alone
by: Claudia I. Perez, et al.
Published: (2019-11-01)

The Next Generation of Obesity Treatments: Beyond Suppressing Appetite
by: Nicole M Avena, et al.
Published: (2013-10-01)

Glucagon-Like Peptide 1 and Taste Perception: From Molecular Mechanisms to Potential Clinical Implications
by: Mojca Jensterle, et al.
Published: (2021-01-01)